Impact Stewards congratulates the Nierstichting on breakthrough innovation
In a nutshell
This week, patient organisation the Nierstichting reported a breakthrough milestone for the Neokidney: a home dialysis solution set to improve quality of life of people with a dialysis need. Impact Stewards is involved in this groundbreaking project. What milestones have been taken, and what exactly has been our role?
Promising to improve kidney patients’ quality of life
Worldwide, around 2.8 million kidney patients must visit a hospital three times a week for lengthy haemodialysis sessions to purify their blood using an artificial kidney. These life-saving machines are large and immobile, leaving patients with little freedom to travel or spend time away from home. To give these patients greater independence, the Nierstichting started a groundbreaking innovation in 2014: the Neokidney. This portable artificial kidney is about the size of carry-on luggage, and can be used anywhere.
Working together across the healthcare system
Over the past ten years, European clinical trials have been conducted, including safety studies and first tests in France, which produced positive results. The mobile dialysis system is now being tested for longer-term use by around 50 patients at the UMC Utrecht. The Nierstichting announced last week that it expects to launch the Neokidney in The Netherlands in 2027.
An integrated service concept
A medical device can be technically ready for the market, but its real impact depends on whether the healthcare ecosystem is prepared. We are proud that Impact Stewards is involved in the design of an innovative home service concept and in contributing to the thinking beyond the device itself.
Impact Stewards is involved in delivering an integrated service concept for the Neokidney. This is involves designing and organising care in the home setting, as well as aligning clinical workflow and funding pathways.
Impact Steward Connie van Marrewijk explains:
“For and with the Nierstichting, we work closely for health insurance companies, care providers. All united around the goal of making home dialysis the safe default option for eligible patients. By focusing not only on the product, but also on the services, partnerships and incentives that make adoption possible, we can truly improve patients’ daily lives.”

“By focusing not only on the product, but also on the services, partnerships and incentives that make adoption possible, we can truly improve patients’ daily lives.” – Connie van Marrewijk
Improving patients’ lives
Chief Impact Officer Patrick Filius adds:
“The Nierstichting truly stood up for its patients by initiating this innovation. It took a holistic approach and brought together patients, healthcare professionals, insurers and innovators to make home dialysis a realistic and scalable option. We look forward to continuing supporting this and other initiatives that turn groundbreaking medical innovation into real-world solutions that improve lives.”

“The Nierstichting truly stood up for its patients by initiating this innovation.” – Patrick Filius
Doing better for patients, society, and the planet
Curious what we can do for you?
Patrick Filius
Chief Impact Officer
Chief Impact Officer
patrick.filius@impactstewards.com